> top > docs > PMC:7204657 > spans > 1424-2050 > annotations

PMC:7204657 / 1424-2050 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
67 525-543 Gene denotes C-reactive protein Gene:1401
68 545-548 Gene denotes CRP Gene:1401
69 37-45 Species denotes patients Tax:9606
70 617-625 Species denotes patients Tax:9606
71 287-298 Chemical denotes tocilizumab MESH:C502936
72 415-426 Chemical denotes tocilizumab MESH:C502936
73 13-27 Disease denotes critically ill MESH:D016638
74 28-36 Disease denotes COVID-19 MESH:C000657245
75 311-319 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T10 100-110 Body_part denotes intestinal http://purl.org/sig/ont/fma/fma7199
T11 145-155 Body_part denotes intestinal http://purl.org/sig/ont/fma/fma7199
T12 259-269 Body_part denotes intestinal http://purl.org/sig/ont/fma/fma7199
T13 464-474 Body_part denotes intestinal http://purl.org/sig/ont/fma/fma7199
T14 536-543 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T16 28-36 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T17 259-281 Disease denotes intestinal perforation http://purl.obolibrary.org/obo/MONDO_0006807
T18 311-319 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T19 464-486 Disease denotes intestinal perforation http://purl.obolibrary.org/obo/MONDO_0006807

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T18 100-110 http://purl.obolibrary.org/obo/UBERON_0000160 denotes intestinal
T19 100-110 http://www.ebi.ac.uk/efo/EFO_0000834 denotes intestinal
T20 145-155 http://purl.obolibrary.org/obo/UBERON_0000160 denotes intestinal
T21 145-155 http://www.ebi.ac.uk/efo/EFO_0000834 denotes intestinal
T22 259-269 http://purl.obolibrary.org/obo/UBERON_0000160 denotes intestinal
T23 259-269 http://www.ebi.ac.uk/efo/EFO_0000834 denotes intestinal
T24 464-474 http://purl.obolibrary.org/obo/UBERON_0000160 denotes intestinal
T25 464-474 http://www.ebi.ac.uk/efo/EFO_0000834 denotes intestinal

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T9 287-298 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T10 415-426 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T11 536-543 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T3 442-462 http://purl.obolibrary.org/obo/GO_0006953 denotes acute phase response

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T13 0-174 Sentence denotes Furthermore, critically ill COVID-19 patients may have altered hemodynamics, potentially leading to intestinal hypoperfusion that can compromise intestinal mucosal integrity.
T14 175-403 Sentence denotes More studies are required to evaluate whether these variables influence the risk of intestinal perforation with tocilizumab in critical COVID-19 cases; however, clinicians should be aware of the potential for this adverse event.
T15 404-626 Sentence denotes Lastly, as tocilizumab attenuates the acute phase response, intestinal perforation may not necessarily cause significant C-reactive protein (CRP) elevation and may initially go unnoticed in sedated and ventilated patients.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T8 259-281 Phenotype denotes intestinal perforation http://purl.obolibrary.org/obo/HP_0031368
T9 442-462 Phenotype denotes acute phase response http://purl.obolibrary.org/obo/HP_0033331
T10 464-486 Phenotype denotes intestinal perforation http://purl.obolibrary.org/obo/HP_0031368